Your browser doesn't support javascript.
loading
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac, Michel; Rosenow, Felix; Toledo, Manuel; Terada, Kiyohito; Li, Ting; De Backer, Marc; Werhahn, Konrad J; Brock, Melissa.
Afiliação
  • Baulac M; Neurology Department (APHP/IHU-ICM), Hôpital de la Pitié-Salpêtrière, Paris, France. Electronic address: michel.baulac@psl.aphp.fr.
  • Rosenow F; Epilepsy Centre Frankfurt Rhine-Main, Neurocentre, Goethe-University, Frankfurt am Main, Germany.
  • Toledo M; Hospital Vall d'Hebron, Barcelona, Spain.
  • Terada K; Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.
  • Li T; UCB Pharma, Raleigh, NC, USA.
  • De Backer M; UCB Pharma, Brussels, Belgium.
  • Werhahn KJ; UCB Pharma, Monheim am Rhein, Germany.
  • Brock M; UCB Pharma, Raleigh, NC, USA.
Lancet Neurol ; 16(1): 43-54, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27889312

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbamazepina / Resultado do Tratamento / Epilepsia / Acetamidas / Anticonvulsivantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbamazepina / Resultado do Tratamento / Epilepsia / Acetamidas / Anticonvulsivantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article